Hi all,

I'm new to this and invest mainly on the fundamentals of a company. I am slowly learning some of the charting side (still a bit sceptical) and would appreciate any views on Skyepharma, a share I have a fairly large holding in, from a chartist perspective

Ianwas

3 is a complete non runner in my opinion, if it was to be a tie up between SKP and innovata it would have to be structured as SKP taking out Innovata or a merger (but with Innovata mgmt being installed). Reasoning for this is the change of ownership clause SKP has in some of the contracts with the pharma partners it already has